Stockreport

Soliton to Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019

Soliton, Inc.  (SOLY) 
PDF HOUSTON, Oct. 8, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technolo [Read more]